Cavendish Financial plc (LON:CAV – Get Free Report) insider Ben Procter purchased 1,653 shares of the company’s stock in a transaction dated Wednesday, December 11th. The shares were purchased at an average price of GBX 10 ($0.13) per share, for a total transaction of £165.30 ($208.63).
Cavendish Financial Stock Performance
Shares of CAV stock opened at GBX 10.10 ($0.13) on Friday. Cavendish Financial plc has a 12-month low of GBX 7.50 ($0.09) and a 12-month high of GBX 15 ($0.19). The company has a market cap of £33.57 million, a price-to-earnings ratio of -1,010.00 and a beta of 1.23. The stock has a 50 day simple moving average of GBX 10.12 and a 200-day simple moving average of GBX 11.52.
Cavendish Financial Increases Dividend
The business also recently disclosed a dividend, which was paid on Wednesday, December 11th. Investors of record on Thursday, November 21st were issued a dividend of GBX 0.30 ($0.00) per share. The ex-dividend date was Thursday, November 21st. This represents a yield of 2.73%. This is an increase from Cavendish Financial’s previous dividend of $0.25. Cavendish Financial’s payout ratio is currently -20,000.00%.
Cavendish Financial Company Profile
Cavendish Financial plc provides various financial services to growth companies in the United Kingdom. The company offers equities research, distribution and execution, and analytics services. It provides investment banking services, such as strategic advisory and capital raising services comprising public market fund raisings, including placings, rights issues, and open offers; IPOs; sell-side or buy-side private M&A; public company M&A; debt arrangement and advice; private capital fund raisings; and general advice on strategic options, as well as acts as a corporate broker/NOMAD on a retained basis.
Featured Stories
- Five stocks we like better than Cavendish Financial
- What is a Secondary Public Offering? What Investors Need to Know
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What is Insider Trading? What You Can Learn from Insider Trading
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Cavendish Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavendish Financial and related companies with MarketBeat.com's FREE daily email newsletter.